Anticoagulation Trends and Forecast
The future of the global anticoagulation market looks promising with opportunities in the atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism markets. The global anticoagulation market is expected to reach an estimated $43.065065225788 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases and growing adaption of novel oral anticoagulants.Anticoagulation by Segment
The study includes a forecast for the global anticoagulation by drug class , application, route of administration, and region.Anticoagulation Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]
- Novel Oral Anticoagulants
- Heparin & Low Molecular Weight Heparin
- Vitamin K Antagonist
- Others
Anticoagulation Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]
- Oral
- Injectable
Anticoagulation Market by Application [Shipment Analysis by Value from 2018 to 2030]
- Atrial Fibrillation/Myocardial Infarction
- Deep Vein Thrombosis
- Pulmonary Embolism
- Others
Anticoagulation Market by Region [Shipment Analysis by Value from 2018 to 2030]
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Anticoagulation Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies anticoagulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoagulation companies profiled in this report include-- Johnson & Johnson
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
Anticoagulation Market Insights
The publisher forecasts that novel oral anticoagulants is expected to witness the highest growth over the forecast period due to usage for the prevention and treatment of atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism.Within this market, atrial fibrillation/myocardial infarction will remain the largest segment due to increased usage of anticoagulants in the treatment.
North America is expected to witness highest growth over the forecast period due to high occurence of cardiovascular disorders.
Features of the Global Anticoagulation Market
- Market Size Estimates: Anticoagulation market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Anticoagulation market size by drug class, route of administration, application, and region in terms of value ($B).
- Regional Analysis: Anticoagulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different drug class, route of administration, application, and regions for the anticoagulation market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoagulation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the anticoagulation market size?Answer: The global anticoagulation market is expected to reach an estimated $43.065065225788 billion by 2030.
Q2. What is the growth forecast for anticoagulation market?
Answer: The global anticoagulation market is expected to grow with a CAGR of 7.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the anticoagulation market?
Answer: The major drivers for this market are growing prevalence of chronic diseases and growing adaption of novel oral anticoagulants.
Q4. What are the major segments for anticoagulation market?
Answer: The future of the anticoagulation market looks promising with opportunities in the atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism markets.
Q5. Who are the key anticoagulation market companies?
Answer: Some of the key anticoagulation companies are as follows:
- Johnson & Johnson
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
Answer: The publisher forecasts that novel oral anticoagulants is expected to witness the highest growth over the forecast period due to usage for the prevention and treatment of atrial fibrillation/myocardial infarction, deep vein thrombosis, and pulmonary embolism.
Q7. In anticoagulation market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to high occurence of cardiovascular disorders.
Q.8 Do we receive customization in this report?
Answer: Yes,the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the anticoagulation market by drug class (novel oral anticoagulants, heparin and low molecular weight heparin, vitamin K antagonist, and others), route of administration (oral and injectable), application (atrial fibrillation/myocardial infarction, deep vein thrombosis, pulmonary embolism, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Anticoagulation Market: Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
